Chemotherapy plays a significant role in glioma treatment; however, it has limited effectiveness in extending the life expectancies of glioma patients. Traditional studies have attributed this lack of efficacy to glioma stem cells (GSCs) and their high resistance to chemotherapy, and hypoxia worsens this issue. In contrast, hyperoxia effectively alleviates hypoxia in glioma and sensitizes glioma cells to chemotherapy. In a summary of traditional studies, the majority of researchers overlooked the influence of hypoxia on differentiated cells because they only focused on the maintenance of GSCs stemness, which thus resulted in chemoresistance. Because of this background, we hypothesized that GSCs may be induced through dedifferentiation under hypoxic conditions, and hypoxia maintains GSCs stemness, which thus leads to resistance to chemotherapy. In contrast, hyperoxia inhibits the dedifferentiation process and promotes GSCs differentiation, which increases the sensitization of glioma cells to chemotherapy. Hypoxia-inducible factor-1α (HIF1α) contributes substantially to the stemness maintenance of GSCs and resistance of glioma to chemotherapy; thus, we investigated whether HIF1α regulates the resistance or sensitization of glioma cells to chemotherapy in different oxygen levels. It highlights a novel viewpoint on glioma chemosensitivity from the transformation between dedifferentiation and differentiation in different oxygen levels.
GSCs and differentiated-related protein detection under different oxygen levels.
Immunofluorescence indicated that GL261 CD133 − CD15 −
NESTIN
− cells had an increased expression of CD133, CD15 and NESTIN after hypoxia exposure for 24 h compared with those exposed to normoxia and hyperoxia. Moreover, compared with hyperoxia, CD133 and NESTIN were significantly increased at least two-fold after normoxia exposure for 24 h. However, GFAP, as a differentiated marker of glioma cells, was highly expressed in cells exposed to hyperoxia and exhibited a 3-fold increase compared with those exposed to normoxia and 12-fold compared with hypoxia. There was nearly few GFAP expressed in cells exposed to 1%O 2 or 21%O 2 conditions (Fig. 2D) . Moreover, RT-qPCR indicated that the levels of CD133, CD15 and NESTIN increased in GL261 CD133 − CD15 − NESTIN − cells exposed to 1% O 2 compared with those exposed to 21%O 2 and 95%O 2 . CD133, CD15 and NESTIN were not expressed in hyperoxia conditions. However, the GFAP levels increased in an oxygen concentration-dependent manner, as GFAP expression was 3-fold higher under hyperoxia compared with normoxia and 6-fold higher compared with hypoxia ( Fig. 2E) . Western blot assays subsequently demonstrated that GL261 CD133 − CD15 − NESTIN − cells presented higher expression levels of CD133, CD15 and NESTIN after 1%O 2 exposure for 24 or 48 h than cells exposed to normoxia or hyperoxia. Moreover, the CD133, CD15 and NESTIN levels increased in a time-dependent manner under 1%O 2 conditions, whereas under 21%O 2 , the expression significantly decreased for CD133 and NESTIN in a time-dependent manner from 24 to 48 h. Under hyperoxia, there was the lowest expression of CD133, CD15 or NESTIN. In contrast, GFAP was highly expressed under 21%O 2 and 95%O 2 conditions, with lower detection in 1%O 2 . Furthermore, GFAP increased in a time-dependent manner from normoxia or hyperoxia 24 to 48 h ( 
Growth characteristics for single CD133
− CD15 − NESTIN − glioma cell under different oxygen levels. We detected the influence of oxygen on the growth of CD133 
NESTIN
− cell was plated in each well of 96-well plates, and these plates were cultured in different oxygen levels. The results showed a single GL261 and U87 CD133 − CD15 − NESTIN − cell grew well after seeding, and approximately 75% of the cells (d3 viable cells/d0 seeding cells) survived after different oxygen exposures for 3 days without significant differences ( Fig. 3A,B ; Supplementary Table S1). We subsequently observed and recorded the cell growth at d3, 7, 14 and 21 under different oxygen levels, and the results indicated neurospheres began to form after 1%O 2 exposure for 3 d. Approximately 20% of the surviving cells (d7 spheres/d3 surviving cells) from GL261 and U87 formed neurospheres after 7 d of exposure in 1%O 2 . The neurosphere rates then significantly increased, and 50.2% ± 4.167 from GL261 and 53.0% ± 3.391 from U87 (d14 spheres/d3 surviving cells) surviving cells formed neurospheres after hypoxia exposure for 14 d. More surprisingly, the sphere rates eventually reached 93.1% ± 5.541 from GL261 and 95.6% ± 2.665 from U87 (d21 spheres/d3 surviving cells) under hypoxic conditions for 21 d. However, under normoxia or hyperoxia, most cells remained a single cell and eventually died ( Fig. 3A,C ; Supplementary Table S1 ).
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Newly formed neurospheres in hypoxic environment presented the features of GSCs. Newly formed neurospheres from GL261 CD133
− CD15 − NESTIN − cells in hypoxia highly expressed the stem cell markers CD133, CD15 and NESTIN according to the immunofluorescence results. Furthermore, the chemoresistance-related proteins ABCG2 and MGMT significantly increased in these neurospheres (Fig. 3D) . RT-qPCR and western blot assays also showed that CD133, CD15, NESTIN, ABCG2 and MGMT in GL261 newly formed neurospheres exhibited higher expression levels compared with control CD133 − CD15 − NESTIN − cells cultured in normoxia ( Fig. 3E; Supplementary Figure S2) . Similar results were obtained in U87 newly formed 
NESTIN
− cells via RT-qPCR compared with normoxia, and MGMT was fewer in 95%O 2 . Similar results were obtained for ABCG2 in different oxygen levels (P < 0.05, One-way ANOVA). (C) There were significant differences in MGMT and ABCG2 for GL261 CD133
− cells under different oxygen levels in western blot; the highest expression was identified in 1%O 2 , and the lowest expression was demonstrated in 95%O 2 (P < 0.05, One-way ANOVA). Both MGMT and ABCG2 increased levels in a time dependent manner from hypoxia for 24 to 48 h. However, under hyperoxia, MGMT expression remained stable; for ABCG2, there was lower expression after hyperoxia treatment (P < 0.05, One-way ANOVA). (D) Compared with 21%O 2 or 95%O 2 , increased CD133, CD15 and NESTIN levels were identified for GL261 CD133 In contrast, GFAP was highly expressed after hyperoxia exposure for 24 h, which exhibited 3-fold increases compared with normoxia and 12-fold compared with hypoxia. There was almost no GFAP expression in the 1%O 2 or 21%O 2 microenvironments (P < 0.05, One-way ANOVA). (E) RT-qPCR indicated the CD133, CD15 and NESTIN levels significantly increased in 1%O 2 for 12 h compared with 21%O 2 and 95%O 2 for GL261 CD133
− cells. However, the GFAP levels increased in an oxygen concentration-dependent manner, and GFAP was 3-fold higher under hyperoxia than normoxia and 6-fold higher than hypoxia. A neurospheres (data not shown). Trypan blue staining was used to determine whether these cells in neurospheres were alive, and we found there were no cells with blue staining in the cytoplasm (Fig. 3F) . Asymmetric division, one of the most important characteristics of GSCs 22 , was detected under 21%O 2 environment in GSC medium (DMEM/F12 + EGF + FGF2 + B27) or differentiated medium (DMEM/F12 + 10%FBS) for newly formed neurospheres. The results showed the cells maintained growth in suspension with a sphere morphology when cultivated in GSC medium for 5 d; however, adherent growth with a differentiation style was induced after 10%FBS administration (Fig. 3G) . Besides, in vivo, the cells digested by GL261-luc neurospheres showed higher tumorigenic when implanting into C57 mice brain than control GL261-luc CD133 2 ; moreover, the number of neurospheres increased in a time-dependent manner in hypoxia exposure from 1 to 5 d. In 21%O 2 , some neurospheres also persisted after exposure for 5 d; however, the number of neurospheres was substantially fewer than those observed in 1%O 2 . Furthermore, the size of the neurospheres under 21%O 2 was substantially smaller. However, in 95%O 2 , no neurospheres formed after 5d of exposure (Fig. 4A,B) . With respect to the cell numbers of U87 CD133
neurospheres after cultivation with different oxygen levels, we found there were no differences among 1%O 2 , 21%O 2 and 95%O 2 on d2. After three days, the cell numbers in 1%O 2 and 21%O 2 increased in a time-dependent manner. In contrast, the number of cells under 95%O 2 gradually decreased (Fig. 4C ).
Protein expression in CD133
+ CD15 + NESTIN + neurospheres exposed to 1%O 2 , 21%O 2 and 95%O 2 . U87 CD133
+ NESTIN + cells digested from newly formed neurospheres highly expressed CD133, NESTIN, ABCG2 and MGMT after 1%O 2 exposure for 24 h. Moreover, hypoxia inhibited GFAP expression. In contrast, there was reduced CD133, NESTIN, ABCG2 and MGMT expression in U87 CD133 + CD15 + NESTIN + cells exposed to 21%O 2 compared with those exposed to hypoxia. However, GFAP expression increased in cells exposed to 21%O 2 . We subsequently compared the expression of these proteins in U87 CD133
+ CD15 + NESTIN + cells between 21%O 2 and 95%O 2 and determined that there was increased GFAP expression in cells exposed to 95%O 2 . However, the expression of CD133, NESTIN, ABCG2 and MGMT significantly decreased after exposure to 95%O 2 for 24 h (Fig. 4D ). Western blot assays indicated similar results ( Fig. 4E; Supplementary Figure S3A ,B). Furthermore, western blotting showed that the expression of CD133, CD15, NESTIN, ABCG2 and MGMT increased in cells exposed to 1%O 2 in a time-dependent manner from 24 to 48 h. However, in the 21%O 2 and 95%O 2 environments, these proteins remained stable or decreased in a time-dependent manner. In contrast, GFAP expression significantly increased in cells exposed to 95%O 2 for 48 h compared with cells exposed to the same treatment for 24 h. However, in 1%O 2 or 21%O 2 , the expression remained stable ( Fig. 4E; Supplementary Figure S3C ,D). RT-qPCR indicated the same results that hypoxia maintained or promoted the expression of CD133, CD15, NESTIN, ABCG2 and MGMT in U87 CD133 + CD15 + NESTIN + cells (Fig. 4F) Table S2A) .
significant difference was also identified between the 1%O 2 and 21%O 2 microenvironments (P < 0.05, One-way
− NESTIN − cells presented the highest expression of CD133, CD15 and NESTIN after 1%O 2 exposure for 24 or 48 h. Furthermore, CD133, CD15 and NESTIN increased levels in a time-dependent manner from hypoxia for 24 to 48 h; however, under 21%O 2 conditions, the expression levels significantly decreased for CD133 and NESTIN in a time-dependent manner. Under 95%O 2 , CD133, CD15 and NESTIN were the lowest expression. In contrast, GFAP was highly expressed in 21%O 2 and 95%O 2 with lower detection under 1%O 2 conditions. Furthermore, the GFAP levels increased in a time-dependent manner from normoxia or hyperoxia for 24 to 48 h (P < 0.05, One-way ANOVA). − CD15 − NESTIN − cell was seeded in the wells of 96-well plates and cultured in 1%O 2 , 21%O 2 and 95%O 2 . Approximately 75% of cells survived after exposure to different oxygen levels for 3 days without a significant difference (d3 viable cells/d0 seeding cells). The neurospheres began to form after 1%O 2 exposure for 3 d, and approximately 20% of cells (d7 spheres/d3 surviving cells) from GL261 and U87 formed neurospheres on day 7. The neurosphere formation rates then significantly increased, and 50.2% ± 4.167 from GL261 and 53.0% ± 3.391 from U87 (d14 spheres/d3 surviving cells) formed neurospheres after hypoxia exposure for 14 d. More surprisingly, the sphere rates eventually reached 93.1% ± 5.541 from GL261 and 95.6% ± 2.665 from U87 (d21 spheres/d3 surviving cells) under hypoxic conditions for 21 days. However, in normoxia or hyperoxia, no distinct neurospheres formed, and most cells remained a single cell and eventually died ( * P < 0.05; ** P < 0.05; + CD15 + NESTIN + neurospheres maintained growth in suspension with a sphere morphology under 1%O 2 conditions; under 21%O 2 , some neurospheres also existed after exposure for 5 d. However, there were no neurospheres after 95%O 2 exposure for 5 d. (B) The number of neurospheres increased in a time-dependent manner from hypoxia exposure for 1 to 5 d; compared with 21%O 2 , the number of neurospheres in 1%O 2 was substantially increased, whereas under hyperoxic conditions, few neurospheres were detected ( * P < 0.05; ** P < 0.05; # P < 0.05, One-sample T Test, One-way ANOVA). (C) There were no differences among the different oxygen levels on day 2 for the cell number of U87 CD133 + CD15 + NESTIN + neurospheres. After three days, the number of cells under 95%O 2 gradually decreased. In contrast, the cell numbers in 1%O 2 and 21%O 2 increased in a time-dependent manner, and the cell proliferation rate of cells in 1%O 2 neurospheres, which demonstrated a significant difference compared with CD133 − /CD15 − /NESTIN − cells (Fig. 5D) . A cell apoptosis examination indicated that U87 CD133 + /CD15 + /NESTIN + neurospheres exhibited a lower apoptosis rate after exposure to TMZ (100 μM) for 48 h than CD133 − /CD15 − /NESTIN − cells with the same TMZ treatment (Fig. 5E) (Fig. 5G) . TMZ (100 μM) was subsequently added to these cells, which were cultured for an additional 48 h, followed by cell apoptosis detection. We determined there was a lower cell apoptosis rate in hypoxia than normoxia (Fig. 5H) . Furthermore, the results indicated that U87 CD133
+ cells in 1%O 2 had a higher survival rate after TMZ treatment, and the IC50 value was approximately 1.3-fold higher than that of control normoxia-treated cells ( Fig. 5I; Supplementary Table S2C ). Hyperoxia presented an opposite effect, which resulted in the lowest rate of G 0 /G 1 and the highest apoptosis rate (Fig. 5G,H, J; Supplementary Table S2C ).
Higher levels of HIF1α in hypoxia, and hyperoxia inhibited HIF1α. U87 CD133 − /CD15 − /NESTIN − cells were cultivated in different oxygen levels for 24 h, and the immunofluorescence results indicated the highest HIF1α expression occurred in cells exposed to 1%O 2 , and no HIF1α was detected in cells exposed to 95%O 2 . However, the dramatic difference from traditional studies was that most HIF1α was located in the cell cytoplasm, with a limited amount located in the cell nucleus. Under normoxic conditions, some HIF1α was detected in U87 CD133
− /CD15 − /NESTIN − cells; HIF1a expression was decreased 2-fold under these conditions compared with the cells exposed to hypoxia and increased 2-fold compared with those exposed to a hyperoxic environment (Fig. 6A) . Similar results were obtained for RT-qPCR, and HIF1α expression was significantly decreased in U87 CD133
− /CD15 − /NESTIN − cells with an increase in oxygen-level dependence (Fig. 6B) . Western blotting indicated the highest levels of HIF1α were observed in cells exposed to 1%O 2 , and HIF1α expression decreased when the oxygen level increased for U87 CD133 − /CD15 − /NESTIN − cells (Fig. 6C) . Furthermore, GL261 neurospheres formed in 1%O 2 also highly expressed HIF1α (Fig. 6D) . We subsequently digested U87 neurospheres and prepared cell suspensions and cultured them in different oxygen levels for 24 h. According to immunofluorescence, HIF1α expression in U87 neurospheres cultured in 1%O 2 was approximately 5.5-fold higher than that of cells exposed to normoxia. Furthermore, HIF1α significantly decreased after hyperoxia exposure compared with the cells cultured in 21%O 2 (Fig. 6E) . Similar results were obtained via RT-qPCR and western blot (Fig. 6F ,G, Supplementary Figure S4A-B) .
Influences of HIF1α on protein expression and cell apoptosis. We subsequently knocked down the HIF1α gene through Sh-RNA for U87 CD133 − /CD15 − /NESTIN − cells, and western blotting assays indicated that the HIF1α expression was lost compared with the control and vector cells in 1%O 2 (Fig. 7A) . We cultured these cells for 48 h in hypoxia and determined that the expression levels of CD133, CD15, NESTIN, ABCG2 and MGMT were significantly decreased for the ShRNA U87 CD133 − /CD15 − /NESTIN − cells compared with the control and vector cells ( Fig. 7A; Supplementary Figure S5A) . Moreover, in hypoxic conditions, U87 CD133 − / CD15 − /NESTIN − cells with HIF1α interference presented a decrease in neurosphere formation at 21 d, with its rate at approximately 66.50 ± 3.10% However, the neurosphere formation rates were greater than 90% for both the control and U87 vector cells, and the size of the neurospheres was substantially larger than that for U87 HIF1α silencing cells under hypoxic conditions (Supplementary Figure S6A ,B, Table S3 ). Furthermore, the ShRNA U87 CD133 − /CD15 − /NESTIN − cells also presented a higher apoptosis rate, which was increased approximately 3.6-fold compared with the control and U87 vector cells (Fig. 7B) Fig. 7D; Supplementary Figure S5B ), which resulted in lower apoptosis rates and an increased IC50 (Fig. 7E,F (Fig. 7G) . We cultured these GSCs in a hypoxic environment with digoxin and added TMZ (100 μM) into the cell suspension for 48 h, which resulted in higher cell apoptosis (Fig. 7H) , a lower survival rate and a 2-fold decrease of IC50 than the control cells without digoxin treatments ( Fig. 7I ; Supplementary  Table S2F ).
Discussion
The main focus of this study was to investigate the mechanism of glioma cell chemosensitivity in different oxygen levels. Traditional studies have ascribed the chemoresistance of glioma to GSCs as a result of the higher expression of chemoresistance-related proteins, such as ABCG2 and MGMT 3, 8, 11, [23] [24] [25] . However, other types of glioma cells exist, which we referred to as normal differentiated glioma cells. In contrast to GSCs, differentiated glioma cells are more sensitive to chemotherapy drugs, such as TMZ 6, 7, 11 . Conventional chemotherapy only kills differentiated glioma cells and leaves GSCs intact, which results in chemoresistant glioma 26 . Furthermore, it has been reported that the chemoresistance of GSCs is markedly decreased if GSCs differentiate into normal differentiation glioma cells that exhibit specific differentiation hallmarks, such as GFAP 7, 11, 27 . Therefore, we conclude that the relationship between GSCs and normal differentiated glioma cells is of vital importance to glioma cell chemosensitivity. Hypoxia in glioma also plays an important role in the maintenance of GSC stemness, which thus promotes glioma chemoresistance 20, 28 . Recently, researchers have cultivated unsorted glioma cells with stem cell medium in a hypoxic environment, and their results indicated a higher expression of stem cell markers, such as CD133, sox-2 and oct-4 13, 14, 29 . There is no doubt that the enhanced expression of CD133 may be due to the proliferation of CD133
+ cells that exist in the unsorted cells; however, another possibility exists that these enhanced CD133 cells originate from differentiated cells through dedifferentiation. Actually, this phenomenon has been proved by our team recently, in this study we found cancer stem cells, including glioma, hepatom and lung cancer, can be induced through dedifferentiation in hypoxia 30, 31 . In contrast, as an effective way to alleviate a hypoxic environment, hyperoxia promotes the sensitivity of glioma cells to TMZ by decreasing the expression of MGMT, ABCG2 and Ki67 and inducing a higher cell apoptosis rate, resulting in an extended survival time for glioma patients 15, 16, 18, 19, 32 . However, the detailed mechanism requires further investigation. For normal stem cells, such as neural stem cells (NSCs) and mesenchymal stem cells (MSCs), researchers have indicated that hyperoxia promotes differentiation and inhibits the expression of stem cell markers [32] [33] [34] . Unfortunately, to date, the influence of hyperoxia on glioma stem cells has not been clearly understood. Therefore, these studies suggest GSCs may be induced through dedifferentiation under hypoxic conditions, and hypoxia also contributes to the maintenance of stemness, which thus results in chemoresistance. In contrast, differentiated glioma cells may have differentiated from GSCs under hyperoxic conditions, and hyperoxia inhibits the dedifferentiation process.
Because of the query of CD133 as a GSC marker 2, 10, 35 , we combined CD133 with CD15 36 and NESTIN 2, 37, 38 as GSC markers to improve the validity of our study, and GFAP 7, 11, 27 was used as the differentiated marker of glioma cells according to traditional studies. Differentiated CD133
− glioma cells were initially sorted through magnetic cell sorting (MACS) and cultured under 1%O 2 , 21%O 2 and 95%O 2 conditions. After 1%O 2 exposure, hypoxia promoted the expression of GSC markers and inhibited GFAP. However, hyperoxia presented the opposite effects and resulted in an inhibition of these stem cell markers with an increase in GFAP. Here 
GSCs as a result of contamination when sorting CD133
− /CD15 − /NESTIN − glioma cells 35 . To avoid this possibility, we detected the rate of newly formed neurospheres by a single CD133 − /CD15 − /NESTIN − glioma cell; the results indicated that more than 95% glioma cells (d21 neurospheres/d3 viable cells) formed neurospheres with an increased expression of CD133, CD15 and NESTIN after hypoxia exposure for 21 d; however, the cells cultured in normoxia or hyperoxia maintained a single cell and eventually died. Some neurospheres that formed in 1%O 2 originated from CD133 + /CD15 + /NESTIN + GSCs; however, the proportion of GSCs in glioma was less than 20% 2, 39 . Thus, the other 75% (75% = 95-20%) of newly formed neurospheres should be from CD133 − / CD15 − /NESTIN − glioma cells through dedifferentiation. Furthermore, the CD133
− /NESTIN − cells were sorted through MACS at least three times; as a result, the proportion of CD133 + /CD15 + /NESTIN + GSCs should be less than 20%.
Traditional studies have indicated that the chemoresistance-related proteins ABCG2 and MGMT are highly expressed in GSCs 3, 23, 25 . This is one of the reasons why GSCs have a higher chemoresistance than non-GSCs. To investigate whether this theory is valid, we detected cell apoptosis for sorted CD133 + /CD15 + /NESTIN + GSCs after TMZ treatments, and the results indicated that GSCs exhibited a lower apoptosis rate. In our study, we determined that the levels of ABCG2 and MGMT were significantly increased, in addition to the high expression of stem cell markers for differentiated CD133 − /CD15 − /NESTIN − cells after hypoxia treatment; moreover, the expression levels of ABCG2 and MGMT decreased in hyperoxia. Newly formed neurospheres in hypoxia also highly expressed ABCG2 and MGMT. We subsequently added TMZ to the cell suspensions and cultured them in different oxygen levels for an additional 48 h; the differentiated CD133 − /CD15 − /NESTIN − cells under hypoxic conditions had the lowest apoptosis rate compared with those in normoxia and hyperoxia. The mean IC50 values presented 1.2-fold higher in hypoxia than hyperoxia. According to these results, we conclude that hypoxia induces the formation of GSCs through dedifferentiation from differentiated cells, which results in resistance to chemotherapy drugs, such as TMZ. In contrast, hyperoxia inhibits the dedifferentiation processes, which leads to the sensitization to TMZ.
Researchers have indicated that hypoxia contributes to GSC stemness 11, 12, 28 . For example, in 2009, Li et al. 40 cultivated GSCs in hypoxic conditions and identified a significant enhancement of stem cell activity with a higher expression of CD133 and an easier formation of neurospheres. Therefore, we investigated the influence of different oxygen levels on CD133 + /CD15 + /NESTIN + neurospheres. The results showed in hypoxic conditions, these cells maintained growth in sphere morphology with an increased expression of CD133, CD15 and NESTIN and a decrease of GFAP. In contrast, hyperoxia significantly enhanced the GFAP expression and inhibited CD133, CD15 and NESTIN. Furthermore, under hyperoxic conditions, the cells maintained adherent growth, and there were few neurospheres. We also demonstrated the levels of ABCG2 and MGMT increased under hypoxic conditions, and a significant decrease was identified after hyperoxia treatments. The apoptosis detection indicated these CD133
+ /CD15 + /NESTIN + cells exhibited a higher apoptosis rate in hyperoxia, and the mean IC50 values were substantially lower. Thus, hypoxia maintains GSC stemness to sustain the resistance of glioma to TMZ; in contrast, hyperoxia promotes GSC differentiation, which effectively overrides glioma resistance to TMZ.
Studies have shown that HIF1α contributes to the maintenance of GSC stemness 11, 29 . Furthermore, HIF1α promotes a significant phenotypic shift towards an undifferentiated population through dedifferentiation from normal glioma cells after TMZ treatments 41 . HIF1α regulates the expression of ABCG2 and MGMT, which thus influences sensitivity to TMZ 11, 42 . HIF1α is influenced by oxygen levels; researchers have demonstrated that hypoxia enhances the stability of HIF1α, and HIF1α will be degraded if oxygen levels increase 43, 44 . Thus, we investigated whether HIF1α exerts an influence in our experiments. We initially identified HIF1α as highly expressed in 1%O 2 in differentiated cells and GSCs. However, the HIF1α levels substantially decreased when the oxygen levels increased. Correspondingly, HIF1α silencing significantly inhibited the expression levels of CD133, CD15, NESTIN, ABCG2 and MGMT under hypoxic conditions. Moreover, HIF1α suppression induced cells to exit G 0 /G 1 and induced greater levels of cell apoptosis. In contrast, an increased resistance of TMZ to glioma cells was demonstrated after HIF1α over-expression in 95%O 2 . Moreover, the mean IC50 values were enhanced after HIF1α over-expression in glioma cells compared with the control.
In summary, following an analysis of our results, we conclude that HIF1α facilitates the dedifferentiation of normal glioma cells and maintains GSC stemness to promote chemoresistance. These findings are consistent with those of Auffinger et al. 10 , who showed that GSCs may be induced through dedifferentiation following glioma cell treatment with TMZ. In contrast, hyperoxia exerts the opposite effects, in which chemosensitization is induced through the differentiation of GSCs, and an inhibition of dedifferentiation occurs as a result of the degradation of HIF1α. This study indicates that normal glioma cells and GSCs may be transformed through dedifferentiation and differentiation regulated by HIF1α under different oxygen levels, which therefore influence the sensitivity of glioma cells to chemotherapy. These findings provide a novel target for the treatment of glioma.
Materials and Methods
Cell isolation and Cell culture. GL261 and U87 cells were considered glioma cell lines. We used magnetic cell sorting (MACS; Miltenyi Biotech, Bergisch-Gladbach, Germany) to sort differentiated CD133 − CD15 − NESTIN − glioma cells and CD133 + CD15 + NESTIN + glioma stem cells 45 and the detailed methods of MACS were shown in supplementary materials. GL261 and U87 cells were initially incubated in DMEM/ F12 + 10%FBS medium at 21%O 2 to maintain cell growth. The glioma cells were subsequently digested by 0.25% trypsin, centrifuged and suspended with DMEM/F12 + 10%FBS medium. Second, the cells were centrifuged again and re-suspended in PBS with 0.08%EDTA and 0.5%BSA (PBSE; 10 8 cells/500 μl). Polyclonal rabbit antimouse or human CD133
+ IgGs (Miltenyi Biotech, Germany) was added and maintained at 4 °C for 15 min. The cells were subsequently washed with PBS that contained 1%BSA and centrifuged again. The cells were suspended in PBSE (10 8 cells/300 μl), and goat anti-rabbit IgG MicroBeads (Miltenyi Biotech, Germany) was added to the cell suspension and cultured at 10 °C. After 15 min, the cells were washed at least twice with PBSE. The cell number was counted, and the cells were suspended in 500 μl of PBSE. The cell suspension was poured into a column reservoir, which was placed by a miniMACS magnet and flushed with 500 μl of PBSE; unlabeled nonmagnetic CD133 − cells were collected in a culture flask. The cells retained on the magnet were CD133 + cells. We repeated these steps at least three times to purify the sorted cells. We subsequently used the same methods to sort CD15 Oxygen treatment. Glioma cells were exposed to different oxygen levels (hypoxia, 1%O 2 ; normoxia, 21%O 2 ; hyperoxia, 95%O 2 ) under normobaric conditions with or without TMZ. For hypoxic and normoxic treatments, cells were exposed to corresponding oxygen levels at all times 13 ; for hyperoxic treatment, cells were exposed to 95%O 2 for 60 min every 12 h 15, 16, 46 . CD133 − CD15 − NESTIN − glioma cells were maintained in DMEM/F12 + 1%FBS. For CD133 + CD15 + NESTIN + GSCs, cells were cultured in DMEM/F12 + 1%FBS when comparing the related changes between hypoxia and normoxia; when analyzing the difference between normoxia and hyperoxia, we cultivated the cells in DMEM/F12 + 10%FBS culture medium.
Immunofluorescence staining. New neurospheres formed in hypoxia and glioma cells cultured under different oxygen levels for 24 h were examined for the expression of stem cell markers (CD133, CD15 and NESTIN), differentiated marker (GFAP) and chemoresistance proteins (ABCG2 and MGMT). After treatment, cells were collected and fixed with 4% paraformaldehyde for at least one day. The cells were subsequently washed with PBS and blocked using 10% serum in PBS with 0.5% Triton X-100 for 20 min. The primary antibodies against CD133, CD15, NESTIN, GFAP, ABCG2, MGMT and HIF1α (related information regarding the primary antibodies is presented in Supplementary Table S4) were added to the cell suspension at 4 °C for 24 h. The cells were subsequently washed with PBS for 5 min at least three times and incubated with appropriate fluorophore-labeled secondary antibodies for 1 h at 37 °C. A laser-scanning confocal microscope (LSM780, ZEISS, Germany) was used to obtain images.
Western blot detection. The related protein expression was detected for neurospheres and glioma cells treated with different oxygen levels for 24 and 48 h. Cells were collected and subjected to SDS-PAGE, followed by transfer to nitrocellulose membranes. The cells were blocked with 5% milk and incubated with primary antibodies against β-actin, CD133, CD15, NESTIN, GFAP, ABCG2, MGMT and HIF1α (related information regarding the primary antibodies is presented in Supplementary Table S4 ) for 1 h. HRP-conjugated secondary antibodies were diluted at 1:10,000. Enhanced chemiluminescence was conducted for visualization. The semi-quantitative densitometry was calculated by Quanative-One software.
Real-time quantitative polymerase chain reaction. Neurospheres and glioma cells treated with different oxygen levels for 12 h were assessed for mRNA levels, including CD133, CD15, NESTIN, GFAP, ABCG2, MGMT and HIF1α. The melting, denaturing and annealing temperatures were 94 °C, 5 min, 94 °C, 30 s and 57 °C, 30 s, respectively. The related primer sequences are shown in Supplementary Table S5 .
Flow cytometric analysis. Cells were cultured at different oxygen levels for 48 h, and the cell cycle was detected by flow cytometry (FCM); TMZ (100 μM) was subsequently added to the cell suspension, and the cells were cultured at different oxygen levels for an additional 48 h, followed by apoptosis detection. Neurospheres formed under hypoxia were also examined with regard to the cell cycle. Detailed steps of the detection of cell cycle and apoptosis were performed as follows. Cell cycle: cells were digested with 0.25% pancreatin and prepared as single cell suspension in 4 °C PBS. Then cells were suspended at 5 × 10 5 cells/ml and fixed with ethanol 75% at 4 °C for 24 h. Cells were centrifugated and washed by PBS, and resuspended in 1 ml PI staining solution and incubated 30 min at 37 °C. Cell apoptosis: washed cells in 4 °C PBS and prepared single cell suspension. Counted cells at 1 × 10 6 cells/ml and sucked up 100 μl suspension. Centrifugated and added 195 μl 0.05% trinatriumcitrate-dihydrate and 0.05% Triton X-100 and 5 μl Annexin V-FITC and incubated cells suspension 15 min. Centrifugated again and added 190 μl 0.05% trinatriumcitrate-dihydrate and 0.05% Triton X-100 and 10 μl PI and incubated cells suspension 20 min. Both samples of cell cycle and apoptosis were analysed by FACS (BD Accuri C6, Germany).
IC50 detection.
Cells were seeded into 96-well plates (5,000 cells/well) and cultivated under different oxygen levels for 48 h, followed by exposure in the absence or presence of TMZ (250, 500, 1,000 and 2,000 μM) for an additional 48 h. A total of 10 µl of CCK-8 was mixed with 90 µl of DMEM/F12 + 1%FBS medium, and the 100-µl suspensions were added to each well. After culturing the cell suspensions under different oxygen degrees for an additional 2 h, the OD value was measured with an ELISA reader at an absorbance of 450 nm (Varioskan Flash, Thermo Scientific, USA).
Clonogenicity, trypan blue and asymmetric division assay. CD133 − CD15
− NESTIN − glioma cells were digested, counted and diluted to 1,500 cells/1 ml DMEM/F12 + 10%FBS. A total of 1 µl of the medium was transferred to one well of a 96-well plate, which was pre-coated with 200 μl of serum-free DMEM/F12. Six 96-well plates were used and randomly divided into three groups; one group was cultured at 37 °C with 1%O 2 and 5%CO 2 , the second group was cultivated under 21%O 2 and the last group was incubated with 95%O 2 . The number of surviving cells was counted after exposure for 3 d, and the cell states were recorded at 0, 3, 7, 14 and 21 days (d). The cells were subsequently digested, and the cell suspension was prepared. One milliliter of trypan blue was added to the cell suspension. After three minutes, the cell color was determined under a microscope. We detected asymmetric division and washed and centrifuged the other cell suspension with PBS, following which the cells were transferred to two 24-well plates. One plate was cultured with stem cell medium (DMEM/F12 + EGF + FGF2 + B27), and the second plate was cultured with DMEM/F12 + 10%FBS. All plates were incubated at 37 °C with 21%O 2 and 5%CO 2 , and the cell morphology was recorded at 1, 3 and 5 d. For CD133 + CD15 + NESTIN + neurospheres formed under hypoxic conditions, we centrifuged and collected them. These neurospheres were randomly divided into three 24-well plates and cultivated under 1%O 2 , 21%O 2 and 95%O 2 . The cell morphologies were recorded at days 1, 2, 3, 4 and 5.
HIF1α interference assays. The HIF1α-ShRNA lentivirus and non-targeting control were obtained from Cyagen, Guangzhou. Approximately 10 5 CD133 − CD15 − NESTIN − cells were seeded into 6-well plates, and HIF1α-ShRNA-lentivirus (MOI = 1) was added into 6-well plates. After allowing for cell attachment for 24 h, 1 μg/ml of puromycin was added to 6-well plates, and the cell suspension was cultured for 48 h. These steps were repeated, and cells were collected after one week. Western blot was used to detect the HIF1α expression. Digoxin (TOCRIS, 4583) was used to decrease HIF1α for CD133 + CD15 + NESTIN + glioma stem cells formed under hypoxic conditions. We initially dissolved the effective digoxin concentration to 100 nm/L 28, 47 , and HIF1α expression was detected via Western blot. The same approach was used to prepare HIF1α over-expression CD133 − CD15 − NESTIN − glioma cells. To determine the influence of HIF1α intervening on neurosphere formation under hypoxic conditions, we performed sphere-formation assays as previously described. Moreover, we also determined the expression of related genes and proteins, including CD133, CD15, NESTIN, ABCG2 and MGMT, in 1%O 2 following HIF1α interference with RT-PCR and Western blot. The influences on cell apoptosis and IC50 were determined following HIF1α intervening with flow cytometric and CCK-8.
Preparation GL261-luc cells and implanted cells into C57 mice brain. The detail procedure of GL261-luc cells preparation was according to our last paper recently 31 . GL261-luc cells were then cultured in 1%O 2 
Statistical analyses.
For all statistical analyses, we used SPSS 19.0. The data are presented as the mean ± standard deviations (SDs). Statistical significance was set at P < 0.05, and all P values were two-sided. T test or one-way analysis of variance (one-way ANOVA) were used to evaluate differences when necessary.
